Arch Biopartners Inc Ord (ACHFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 197 | 1,559 | 1,471 | 755 | 3,076 |
| Gross Profit | 197 | 1,559 | 1,471 | 755 | 3,076 |
| Operating Expenses | 1,270 | 4,460 | 3,958 | 1,844 | 0 |
| Operating Income | -1,072 | -2,901 | -2,488 | -1,088 | 3,076 |
| Interest Expense | 185 | 286 | 266 | 242 | 0 |
| Other Income | 147 | 306 | 287 | 228 | 0 |
| Pre-tax Income | -1,110 | -2,881 | -2,467 | -1,103 | 3,076 |
| Net Income Continuous | -1,110 | -2,881 | -2,467 | -1,103 | -926 |
| Net Income | $-1,110 | $-2,881 | $-2,467 | $-1,103 | $-926 |
| EPS Basic Total Ops | -0.02 | -0.05 | -0.04 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.04 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.05 | -0.04 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.05 | -0.04 | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.05 | -0.04 | -0.02 | -0.02 |
| EBITDA(a) | $-888 | $-2,615 | $-2,221 | $-846 | $3,076 |